The genetic basis of myelodysplasia has long been enigmatic, with few common targets of mutation known. A new study reports common mutations in the TET2 gene in myelodysplasia and related myeloid malignancies, suggesting that TET2 has an important role in hematopoiesis and in the pathogenesis of this disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)
Experimental Hematology & Oncology Open Access 21 August 2019
-
Base resolution maps reveal the importance of 5-hydroxymethylcytosine in a human glioblastoma
npj Genomic Medicine Open Access 13 March 2017
-
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes
Genome Biology Open Access 26 May 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Langemeier, S.M.C. et al. Nat. Genet. 41, 838–842 (2009).
Nimer, S.D. Blood 111, 4841–4851 (2008).
Ebert, B.L. et al. Nature 451, 335–339 (2008).
Pedersen-Bjergaard, J., Andersen, M.K., Andersen, M.T. & Christiansen, D.H. Leukemia 22, 240–248 (2008).
Mullighan, C.G. et al. Nature 446, 758–764 (2007).
Delhommeau, F. et al. N. Engl. J. Med. 360, 2289–2301 (2009).
Tefferi, A. et al. Leukemia 23, 905–911 (2009).
Abdel-Wahab, O. et al. Blood advance online publication, 10.1182/blood-2009–03–210039 (6 May 2009).
Tefferi, A. et al. Leukemia advance online publication, 10.1038/leu.2009.59 (19 March 2009).
Jankowska, A.M. et al. Blood advance online publication, 10.1182/blood-2009–02–205690 (16 April 2009).
Tefferi, A. et al. Leukemia 23, 900–904 (2009).
Tahiliani, M. et al. Science 324, 930–935 (2009).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mullighan, C. TET2 mutations in myelodysplasia and myeloid malignancies. Nat Genet 41, 766–767 (2009). https://doi.org/10.1038/ng0709-766
Issue Date:
DOI: https://doi.org/10.1038/ng0709-766
This article is cited by
-
TETology: Epigenetic Mastermind in Action
Applied Biochemistry and Biotechnology (2021)
-
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)
Experimental Hematology & Oncology (2019)
-
Base resolution maps reveal the importance of 5-hydroxymethylcytosine in a human glioblastoma
npj Genomic Medicine (2017)
-
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes
Genome Biology (2013)
-
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
Oncogene (2013)
